Karen Ferrante
Direktor/Vorstandsmitglied bei MACROGENICS, INC.
Vermögen: 63 521 $ am 31.05.2024
Aktive Positionen von Karen Ferrante
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MACROGENICS, INC. | Direktor/Vorstandsmitglied | 25.01.2017 | - |
| Independent Dir/Board Member | 25.01.2017 | - | |
| COGENT BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 01.02.2018 | - |
| Independent Dir/Board Member | 01.02.2018 | - | |
New England Women In Science Executives Club
 New England Women In Science Executives Club Miscellaneous Commercial ServicesCommercial Services The New England Women In Science Executives Club is a women's club that provides a platform for members to discuss their challenges, solutions, and ideas. The private company is based in Framingham, MA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Karen Ferrante
Ehemalige bekannte Positionen von Karen Ferrante
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HUTCHMED (CHINA) LIMITED | Direktor/Vorstandsmitglied | 01.02.2017 | 12.05.2023 |
| Independent Dir/Board Member | 01.02.2017 | 12.05.2023 | |
| PROGENICS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 29.01.2014 | 19.06.2020 |
| Independent Dir/Board Member | 29.01.2014 | 19.06.2020 | |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Technik-/Wissenschafts-/F&E-Leiter | 24.04.2014 | 31.08.2016 |
| BAXALTA INC | Direktor/Vorstandsmitglied | 27.07.2015 | 03.06.2016 |
| Independent Dir/Board Member | 27.07.2015 | 03.06.2016 | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.09.2007 | 01.07.2013 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01.09.2007 | 01.07.2013 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Karen Ferrante
| Providence College | Undergraduate Degree |
| Georgetown University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 13 |
| Hong Kong | 2 |
| Japan | 2 |
Operativ
| Director/Board Member | 6 |
| Corporate Officer/Principal | 5 |
| Independent Dir/Board Member | 5 |
Sektoral
| Health Technology | 12 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MACROGENICS, INC. | Health Technology |
| HUTCHMED (CHINA) LIMITED | Health Technology |
| COGENT BIOSCIENCES, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
New England Women In Science Executives Club
New England Women In Science Executives Club Miscellaneous Commercial ServicesCommercial Services The New England Women In Science Executives Club is a women's club that provides a platform for members to discuss their challenges, solutions, and ideas. The private company is based in Framingham, MA. | Commercial Services |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
- Börse
- Insiders
- Karen Ferrante
- Erfahrung
